MESSAGE FROM THE ACTING EXECUTIVE DIRECTOR
Our efforts to strengthen research collaborations are already paving the way towards new partnerships. The monthly research seminars are receiving good numbers and good feedback, while further steps are being taken to establish collaborations which bring together the cross-cutting themes of our priority research areas. While everyone’s working arrangements are being impacted by the pandemic, there are many good stories to tell at the Kolling, from substantial new funding and industry partnerships, to collaborations on nationally and internationally significant projects and a broad range of innovative research. Each breakthrough and step forward in scientific knowledge is getting us closer to new diagnostic tools, informed treatments and improved health outcomes. Have a look through this newsletter and check out the impressive research underway.
We heard about the significant progress being made by these researchers, their exciting projects and tangible improvements to patient care and community health. This showcase was the first of three events to focus on the strengths and diversity of the research priority areas, and broaden awareness of activity across these disciplines. We are now looking forward to the Cardiovascular and Renal Research Showcase on October 8, and the Musculoskeletal Research Showcase early next year. Another key achievement in recent months has been the development of the new research plan. Excellent progress has been made on this strategic document with further input received from the Kolling Executive Committee, the NORTH Foundation and the joint venture partners. Following the consultation, a range of goals, timelines and measurable steps have been established. It is anticipated the research plan will be presented to the Kolling Institute Governance Committee for endorsement this month.
The pandemic has certainly shaped our experience in recent months, impacting our work, families and the delivery of healthcare. Research activity has been affected by the current COVID-19 restrictions, but I have been encouraged by the commitment to progress our important work. Researchers are making every effort to adopt a flexible approach and adapt to the current situation. Teams have found new ways to be collaborative and productive, and where possible, have shifted their focus to dry lab and online arrangements. Critical laboratory work is continuing in line with NSW Health, university and local health district requirements, and a large number of online events are being held. I would like to extend my appreciation and admiration for these efforts. One example of this was the recently staged Neuroscience and Pain Research Showcase. While we weren’t able to meet in person, more than 250 people joined the event online, which profiled the incredibly strong expertise we have across this research priority area.
2
KOLLINGNEWS | SEPTEMBER 2021
Made with FlippingBook - professional solution for displaying marketing and sales documents online